Literature DB >> 88053

Cell-mediated lysis of lipid vesicles containing eye muscle protein: implications regarding pathogenesis of Graves ophthalmopathy.

J P Kriss, S Q Mehdi.   

Abstract

We prepared artificial vesicles that are lysed upon cell-mediated immunological attack by human lymphocytes. These vesicles are made from a mixture of dimyristoyl lecithin, dipalmitoyl lecithin, and cholesterol, have eye muscle membrane protein (EMP) inserted into the bilayer wall, and contain intravesicular (99m)Tc marker. Injury to the vesicular membrane was assessed by measurement of (99m)Tc release. Thyroglobulin (Tg) and Tg-anti-Tg complex (TgA) bind to EMP-vesicles to an extent equal to or greater than to native eye muscle membranes in vitro; this binding requires the presence of normal human IgG. The role of Tg, TgA, IgG, and peripheral blood lymphocytes in altering membrane permeability was analyzed. Incubation of vesicles for up to 3 hr alone, with added IgG alone, or with further addition of Tg or TgA did not result in (99m)Tc release. Addition of lymphocytes from normal donors to the above four preparations showed release in the presence of TgA. Lymphocytes from each of eight patients with Graves ophthalmopathy caused release not only in the presence of TgA, but also in the presence of Tg. Separation of a patient's lymphocytes into high- and low-affinity rosette-formers (T and K cells, respectively) showed that cell-mediated vesicle lysis in the presence of TgA was greater with K cells than with T cells, while vesicle lysis in the presence of Tg was greater with T cells than with K cells. Vesicles made with inserted Tg but lacking EMP were not lysed by such T cells. Lymphocytes failed to induce permeability changes in vesicles containing other inserted proteins obtained from human nonextraocular muscle, liver, spleen, or adrenal, even if Tg or TgA were present. The results support the concept that muscle cell damage in Graves ophthalmopathy is immunological, cell-mediated, and of two types: (i) K lymphocytes reacting to immune complex, TgA, on the eye muscle cell surface (i.e., antibody-dependent cytotoxicity) and (ii) sensitized T lymphocytes reacting to Tg on the eye muscle cell surface. An antigenic role for EMP is possible, but has not been unequivocally proven.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 88053      PMCID: PMC383522          DOI: 10.1073/pnas.76.4.2003

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

Review 1.  Studies on the pathogenesis of Graves' ophthalmopathy (with some related observations regarding therapy).

Authors:  J P Kriss; J Konishi; M Herman
Journal:  Recent Prog Horm Res       Date:  1975

2.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

3.  Extraocular muscles: light microscopy and ultrastructural features.

Authors:  A J Martinez; S Hay; K W McNeer
Journal:  Acta Neuropathol       Date:  1976-03-30       Impact factor: 17.088

4.  The influence of lipid substitution on thyrotropin-receptor interactions in artificial vesicles.

Authors:  S Q Mehdi; S S Nussey; J E Shindelman; J P Kriss
Journal:  Endocrinology       Date:  1977-11       Impact factor: 4.736

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex to extraocular muscle membrane.

Authors:  J Konishi; M M Herman; J P Kriss
Journal:  Endocrinology       Date:  1974-08       Impact factor: 4.736

7.  Prevention of malignant exophthalmos after treatment of thyrotoxicosis.

Authors:  R Winand; P Mahieu
Journal:  Lancet       Date:  1973-05-26       Impact factor: 79.321

8.  Low affinity E-rosette formation by the human K cell.

Authors:  W H West; R B Boozer; R B Herberman
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

9.  Delayed hypersensitivity in Graves' disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle.

Authors:  B R Mullin; R E Levinson; A Friedman; D E Henson; R J Winand; L D Kohn
Journal:  Endocrinology       Date:  1977-02       Impact factor: 4.736

10.  A radio-ligand receptor assay for the long-acting thyroid stimulator. Inhibition by the long-acting thyroid stimulator of the binding of radioiodinated thyroid-stimulating hormone to human thyroid membranes.

Authors:  S Q Mehdi; S S Nussey
Journal:  Biochem J       Date:  1975-01       Impact factor: 3.857

View more
  5 in total

Review 1.  Immunosuppressant therapy of thyroid eye disease.

Authors:  G Kahaly; J Beyer
Journal:  Klin Wochenschr       Date:  1988-11-01

Review 2.  Ocular manifestations of Graves' disease: a review.

Authors:  A P Weetman; A M McGregor; R Hall
Journal:  J R Soc Med       Date:  1984-11       Impact factor: 5.344

3.  The ophthalmopathy of Graves' disease.

Authors:  D Rapoport
Journal:  West J Med       Date:  1985-04

4.  Allogeneic cytolysis of reconstituted membrane vesicles.

Authors:  N Hollander; S Q Mehdi; I L Weissman; H M McConnell; J P Kriss
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

5.  The application of a cytochemical bioassay to measure thyroid stimulating antibodies; a study of patients with euthyroid Graves' ophthalmopathy.

Authors:  P A Ealey; N J Marshall; N Lawton; P Dandona; S Lightman; R P Ekins
Journal:  J Endocrinol Invest       Date:  1984-12       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.